Gamma inulin compositions
AssigneeThe Australian National University
InventorPeter D. Cooper
Life of this patent
Estimating the term…
Abstract
An immunoactive composition comprising particles containing inulin or an inulin derivative in the gamma polymorphic form, an antigen-binding carrier material and optionally an immune modulator such as an antigenic materials or a cytokine. The compositions provide methods for enhancing immune responses. A process for preparation of the compositions is also considered.
Claims31
An immunoadjuvant composition containing particles wherein said particles comprise inulin or an inulin derivative in the gamma polymorphic form in the same particle with an antigen-binding carrier material.
A method for the activation of the alternative pathway of complement in a human or animal body, which comprises administering to the human or animal body an effective amount for said activation of an immunotherapeutic preparation which comprises as an active component thereof particles containing inulin or an inulin derivative in gamma polymorphic form in the same particle with an antigen-binding carrier material;
- and a pharmaceutically acceptable carrier or diluent.
A method for the treatment of an infection by a bacterium, mycoplasma, fungus, virus, protozoan or other microbe, or of an infestation by a worm or parasite, in a human or animal body which comprises administering to the human or animal body an effective amount of an immunotherapeutic preparation which comprises as an active component thereof particles containing inulin or an inulin derivative in gamma polymorphic form in the same particle with an antigen-binding carrier material;
- and a pharmaceutically acceptable carrier or diluent.
A method for the treatment of an infection by a bacterium, mycoplasma, fungus, virus, protozoan or other microbe, or of an infestation by a worm or parasite, in a human or animal body which comprises administering to the human or animal body an effective amount of a vaccine composition comprising particles containing inulin or an inulin derivative in the gamma polymorphic form in the same particle with an antigen-binding carrier material, and one or more antigens adsorbed thereon, together with a pharmaceutically acceptable carrier or diluent.
A method for enhancement of an immune response in a human or animal body to which has been administered an immune modulator which comprises administering to the human or animal body an effective amount for enhancement of an immunotherapeutic preparation which comprises as an active component thereof particles containing inulin or an inulin derivative in gamma polymorphic form in the same particle with an antigen-binding carrier material;
- and a pharmaceutically acceptable carrier or diluent.
Dependencies are inferred from the claim text.